Site-Specific Conjugation of Monomethyl Auristatin E to Anti-CD30 Antibodies Improves Their Pharmacokinetics and Therapeutic Index in Rodent Models (Q38916078)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Site-Specific Conjugation of Monomethyl Auristatin E to Anti-CD30 Antibodies Improves Their Pharmacokinetics and Therapeutic Index in Rodent Models |
scientific article |
Statements
1 reference
Site-Specific Conjugation of Monomethyl Auristatin E to Anti-CD30 Antibodies Improves Their Pharmacokinetics and Therapeutic Index in Rodent Models (English)
1 reference
F Lhospice
D Brégeon
C Belmant
P Dennler
A Chiotellis
L Gauthier
A Boëdec
H Rispaud
S Savard-Chambard
A Represa
N Schneider
C Paturel
M Sapet
C Delcambre
S Ingoure
N Viaud
C Bonnafous
9 February 2015
1 reference